Quantinno Capital Management LP Grows Holdings in Chemed Co. (NYSE:CHE)

Quantinno Capital Management LP boosted its holdings in shares of Chemed Co. (NYSE:CHE) by 29.9% in the third quarter, HoldingsChannel reports. The fund owned 1,587 shares of the company’s stock after acquiring an additional 365 shares during the period. Quantinno Capital Management LP’s holdings in Chemed were worth $954,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the business. Ballentine Partners LLC lifted its holdings in shares of Chemed by 4.1% during the third quarter. Ballentine Partners LLC now owns 655 shares of the company’s stock valued at $394,000 after purchasing an additional 26 shares during the last quarter. Everpar Advisors LLC raised its stake in Chemed by 4.9% during the second quarter. Everpar Advisors LLC now owns 580 shares of the company’s stock valued at $315,000 after buying an additional 27 shares during the last quarter. Creative Planning boosted its holdings in Chemed by 2.8% in the second quarter. Creative Planning now owns 1,228 shares of the company’s stock worth $667,000 after acquiring an additional 34 shares in the last quarter. First Heartland Consultants Inc. grew its stake in shares of Chemed by 7.2% in the third quarter. First Heartland Consultants Inc. now owns 508 shares of the company’s stock worth $305,000 after acquiring an additional 34 shares during the last quarter. Finally, First Trust Direct Indexing L.P. raised its position in shares of Chemed by 4.5% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 887 shares of the company’s stock worth $533,000 after purchasing an additional 38 shares during the last quarter. Institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CHE. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th. Royal Bank of Canada reduced their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th.

Chemed Trading Down 1.2 %

Chemed stock opened at $546.69 on Friday. Chemed Co. has a 12-month low of $523.33 and a 12-month high of $654.62. The firm has a market capitalization of $8.23 billion, a price-to-earnings ratio of 27.62, a P/E/G ratio of 2.32 and a beta of 0.46. The firm has a 50 day moving average of $570.70 and a 200 day moving average of $564.64.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm’s revenue for the quarter was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.32 earnings per share. On average, analysts predict that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.37%. The ex-dividend date was Monday, November 18th. Chemed’s dividend payout ratio (DPR) is 10.11%.

Insider Buying and Selling

In other Chemed news, EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the sale, the executive vice president now directly owns 18,287 shares in the company, valued at approximately $10,526,362.94. The trade was a 3.85 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director George J. Walsh III sold 400 shares of the business’s stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now owns 3,046 shares in the company, valued at approximately $1,819,893.62. The trade was a 11.61 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,132 shares of company stock worth $3,003,502. 3.32% of the stock is owned by corporate insiders.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.